Loss-of-function and gain-of-function mutations in the upper surface of the I-domain-like structure of the integrin β3 subunit.

被引：0
|
作者：
Yamanouchi, J
Hato, T
Tamura, T
Minamoto, Y
Yasukawa, M
Fujita, S
机构：
[1] Ehime Univ, Sch Med, Dept Internal Med 1, Shigenobu, Ehime 79102, Japan
[2] Ehime Univ, Sch Med, Div Blood Transfus, Shigenobu, Ehime 79102, Japan
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1046
引用
收藏
页码：244A / 244A
页数：1
相关论文
共 50 条
  • [41] Dominant Gain-of-Function Mutations in STAT1 and FOXP3+IPEX-Like Disease
    Uzel, Gulbu
    Sampaio, Elizabeth P.
    Lawrence, Monica G.
    Hsu, Amy P.
    Dorsey, Morna
    Freeman, Alexandra F.
    Gambinieri, Eleonora
    Dat, Q. Tran
    Torgerson, Troy R.
    Milner, Joshua
    Holland, Steven M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 386 - 386
  • [42] Humans with loss-of-function mutations in ISG15 display gain-of-function in anti-viral immunity at the expense of increased susceptibility to mycobacteria and auto-immunity
    Speer, Scott D.
    Payelle-Brogard, Beatrice
    Buta, Sofija
    Li, Zhi
    Hermann, Mark
    Garcia-Sastre, Adolfo
    Pellegrini, Sandra
    Bogunovic, Dusan
    CYTOKINE, 2015, 76 (01) : 74 - 75
  • [43] Both loss-of-function and gain-of-function mutations in snf define a role for snRNP proteins in regulating sex-lethal pre-mRNA splicing in Drosophila development
    Salz, HK
    Flickinger, TW
    GENETICS, 1996, 144 (01) : 95 - 108
  • [44] Efficacy and Safety of Alirocumab in Patients With Autosomal Dominant Hypercholesterolemia Associated With Proprotein Convertase Subtilisin/Kexin Type 9 Gain-of-Function or Apolipoprotein B Loss-of-Function Mutations
    Krempf, Michel
    Hopkins, Paul N.
    Bruckert, Eric
    Lee, Shane
    Donahue, Stephen
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (06): : 880 - 886
  • [45] Pharmacokinetic and pharmacodynamic assessment of alirocumab in patients with familial hypercholesterolemia associated with proprotein convertase subtitisin/kexin type 9 gain-of-function or apolipoprotein B loss-of-function mutations
    Hopkins, Paul N.
    Krempf, Michel
    Bruckert, Eric
    Donahue, Stephen
    Yang, Feng
    Zhang, Yi
    DiCioccio, A. Thomas
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (06) : 970 - 978
  • [46] Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome
    Jiang, Xiao
    Raju, Praveen K.
    D'Avanzo, Nazzareno
    Lachance, Mathieu
    Pepin, Julie
    Dubeau, Francois
    Mitchell, Wendy G.
    Bello-Espinosa, Luis E.
    Pierson, Tyler M.
    Minassian, Berge A.
    Lacaille, Jean-Claude
    Rossignol, Elsa
    EPILEPSIA, 2019, 60 (09) : 1881 - 1894
  • [47] Pharmacodynamics of Alirocumab in Patients With Autosomal Dominant Hypercholesterolemia Associated With PCSK9 Gain-Of-Function or ApoB Loss-Of-Function Mutations: An Open-Label Extension Study
    Krempf, Michel
    Hopkins, Paul N.
    Bruckert, Eric
    Luc, Gerald
    Lee, Shane
    Donahue, Stephen
    CIRCULATION, 2018, 138
  • [48] TRPV4 (Transient receptor potential vanilloid 4) ion channel mutations V620I and V620A cause a gain-of-function and a loss-of-function effect, respectively
    Staudner, T.
    Lamande, S.
    Mcintyre, P.
    Korbmacher, C.
    Haerteis, S.
    ACTA PHYSIOLOGICA, 2017, 219 : 145 - 145
  • [49] Phosphate-binding loop and Rab GTPase function:: mutations at Ser29 and Ala30 of Rab5 lead to loss-of-function as well as gain-of-function phenotype
    Li, GP
    Liang, ZM
    BIOCHEMICAL JOURNAL, 2001, 355 (03) : 681 - 689
  • [50] Demonstration of novel gain-of-function mutations of aIIbβ3: association with macrothrombocytopenia and Glanzmann thrombasthenia-like phenotype
    Kashiwagi, H.
    Kunishima, S.
    Kiyomizu, K.
    Amano, Y.
    Shimada, H.
    Morishita, M.
    Kanakura, Y.
    Tomiyama, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 455 - 455
12345